Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
7.35
-0.14 (-1.87%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Bicycle Therapeutics Revenue
In the year 2024, Bicycle Therapeutics had annual revenue of $35.28M with 30.76% growth. Bicycle Therapeutics had revenue of $3.71M in the quarter ending December 31, 2024, a decrease of -30.44%.
Revenue (ttm)
$35.28M
Revenue Growth
+30.76%
P/S Ratio
12.19
Revenue / Employee
$115,656
Employees
305
Market Cap
511.41M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BCYC News
- 16 days ago - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 17 days ago - Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 22 days ago - Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments - Business Wire
- 7 weeks ago - Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 2 months ago - Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 2 months ago - Bicycle Therapeutics: Trading At Cash, Underwhelming But Not Unsalvageable Data - Seeking Alpha
- 3 months ago - Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones - Business Wire
- 3 months ago - Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference - Business Wire